Underlying mechanisms of leprosy recurrence in the Western Amazon: a retrospective cohort study

Abstract

Background The multidrug therapy (MDT) for leprosy treatment adopted by Brazil in the 1990s was important for reducing leprosy in the country; however, recurrent cases remained problematic. Mechanisms involved in leprosy recurrence are heterogeneous and can be sorted into three groups: insufficient therapy, bacillary persistence and new infections. This study aimed to analyse the time interval of leprosy recurrence in relation to the therapeutic scheme in the state of Acre. The hypotheses were as follows: 1) treatments (a) rifampicin, ofloxacin and minocycline (ROM) and (b) dapsone (DDS) have a short leprosy recurrence time, 2) treatments based on MDT have a long leprosy recurrence time, 3) there is a dose-response relationship between MDT and the time interval between leprosy episodes. Methods This retrospective cohort study included 201 patients with a second episode of clinical leprosy at the reference centers for leprosy control in the state of Acre. Exposure was the type of therapeutic scheme as follows: 1) ROM, 2) DDS, 3) MDT 0–9 doses , 4) MDT 10–19 doses , 5) MDT 20–29 doses , and 6) MDT 30+ doses . Outcome was the time interval between release from treatment and a diagnosis of a recurrent leprosy case. Incidence rate ratios and relative risk Poisson regressions adjusted by age and sex were calculated with 95% confidence intervals. Results The 201 patients studied during this retrospective follow-up resulted in a total of 224 cases of recurrent leprosy. Incidence rate ratios within this therapeutic scheme were as follows: 3.3 (2.39, 4.2; ROM/MDT 30+ ), 1.12 (0.33, 1.92; DDS/MDT 30+ ), 2.17 (1.39, 2.94; MDT 0–9 /MDT 30+ ), 1.94 (1.13, 2.75; MDT 10–19 /MDT 30+ ) and 1.26 (0.47, 2.05; MDT 20–29 /MDT 30+ ). Relative risk Poisson regressions showed a protective effect of MDT 30+ in comparison with ROM (0.22; 0.07, 0.72), MDT 0–9 (0.42; 0.21, 0.85), and MDT 10–19 (0.44; 0.21, 0.92). No differences among MDT 30+ and DDS (0.71; 0.36, 1.41) and MDT 20–29 (0.76; 0.38, 1.49) were observed. Conclusions New infection is an important—yet neglected—mechanism in leprosy recurrence in the state of Acre and can challenge the leprosy elimination plan in Brazil. MDT with few doses might be associated with leprosy recurrence due to insufficient therapy or bacillary persistence. Electronic supplementary material The online version of this article (10.1186/s12879-019-4100-6) contains supplementary material, which is available to authorized users. ...

Relapse in leprosy and drug resistance assessment in a tertiary hospital of the state of Espírito Santo, Brazil

“…Twenty-five (83.3%) cases assessed in the present study had relapsed during this period, with an average of 10 years and seven months. This finding was similar to those of the studies conducted by Balagon et al 11 Leprosy recurrence cases that occur with long intervals between the first and second diagnoses, usually > 15 years, are mainly observed in patients continuously exposed to the bacillus 1 . In our study, 12 (40%) patients had reported intradomiciliary contact with patients diagnosed with leprosy, which could explain recurrences resulting from hyperendemicity of the area or reinfection [10][11][12] .…”

“…In 1981, the World Health Organization recommended multidrug therapy (MDT) for treating leprosy. As a result, the prevalence of the disease has decreased worldwide 1 , 3 . However, thousands of new cases are observed in Brazil every year.…”

Geospatial Epidemiology of Leprosy in Northwest Bangladesh: A 20-year Retrospective Observational Study

“…The gradual increase in the number of reported cases after 2012 and 2013, might be due to the roll out of extra case nding surveys, intended to reach the case inclusion targets for the intervention studies that started in those years (24). The heterogeneous spatial epidemiological patterns of leprosy incidence that are shown in this study, are also known to be present in India (20,40,41) and Brazil (42)(43)(44)(45)(46)(47)(48).…”

Multidrug Therapy for Leprosy Can Cure Patients with Lobomycosis in Acre State, Brazil: A Proof of Therapy Study

“…However, Brazil has the highest proportion (70%) of cases (∼500 cases reported to date). 2,6,7 The Acre Dermatology Service 8 in the western Amazon has recorded 317 cases of the disease in mostly male patients living in the forest, with an average age of 52.7 years. Case reports have shown successful outcomes following surgical excision and antifungal and/or antitubercular drug use (e.g., itraconazole, posaconazole, and clofazimine).…”